Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

OTSSP167 (hydrochloride)

Product Specifications

UNSPSC Description

OTSSP167 (OTS167) hydrochloride is a highly potent and ATP-competitive MELK inhibitor with IC50 value of 0.41 nM.

Target Antigen

MELK

Type

Reference compound

Related Pathways

PI3K/Akt/mTOR

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/OTSSP167-hydrochloride.html

Solubility

DMSO : 33.33 mg/mL (ultrasonic)|H2O : 7.14 mg/mL (ultrasonic)

Smiles

ClC1=CC(C2=CC=C(N=CC(C(C)=O)=C3N[C@H]4CC[C@H](CN(C)C)CC4)C3=N2)=CC(Cl)=C1O.[H]Cl

Molecular Weight

523.88

References & Citations

[1]Chung S, Suzuki H, Miyamoto T, et al. Development of an orally-administrative MELK-targeting inhibitor that suppresses the growth of various types of human cancer. Oncotarget. 2012 Dec 21.|[2]Ji W, et al. OTSSP167 Abrogates Mitotic Checkpoint through Inhibiting Multiple Mitotic Kinases. PLoS One. 2016 Apr 15;11(4):e0153518.|[3]Cho YS, et al. The crystal structure of MPK38 in complex with OTSSP167, an orally administrative MELK selective inhibitor. Biochem Biophys Res Commun. 2014 Apr 25;447(1):7-11.|[4]Jurmeister S, et al. Identification of potential therapeutic targets in prostate cancer through a cross-species approach. EMBO Mol Med. 2018 Feb 5. pii: e8274.|[5]Meel MH, et al. MELK inhibition in Diffuse Intrinsic Pontine Glioma. Clin Cancer Res. 2018 Jul 30. pii: clincanres.0924.2018.Clin Cancer Res. 2018 Nov 15;24(22):5645-5657. |Elife. 2017 Mar 24;6:e24179.|Elife. 2018 Feb 8;7:e32838. |EMBO Mol Med. 2018 Mar;10(3). pii: e8274.|Free Radic Biol Med. 2021 Jun 15;S0891-5849(21)00377-4.|Gynecol Oncol. 2017 Apr;145(1):159-166.|Harvard Medical School LINCS LIBRARY|Nat Cancer. 2024 Jul 11.|Neuro Oncol. 2020 Jan 11;22(1):58-69. |Biochem Biophys Res Commun. 2014 Apr 25;447(1):7-11. |Blood Cancer J. 2019 Nov 18;9(12):87.|Int J Oncol. 2022 Jul;61(1):89.|Mol Cancer. 2014 May 4;13:100.|Oncotarget. 2016 Feb 2;7(5):6266-80. |Oncotarget. 2017 Dec 20;9(2):2591-2602. |Patent. US20160291017A1.|PLoS One. 2017 Feb 24;12(2):e0172832. |Sci Rep. 2017 Feb 14;7:42502.

Shipping Conditions

Room Temperature

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-15512A/OTSSP167-hydrochloride-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-15512A/OTSSP167-hydrochloride-SDS-MedChemExpress.pdf

Clinical Information

Phase 2

CAS Number

1431698-10-0

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

OR13H1 Protein Lysate (Human) with C-Ha Tag
34968031 100 μg

OR13H1 Protein Lysate (Human) with C-Ha Tag

Ask
View Details
Plexin A4 (PLXNA4) Antibody
abx135910-01 60 µL

Plexin A4 (PLXNA4) Antibody

Ask
View Details
Plexin A4 (PLXNA4) Antibody
abx135910-02 120 µL

Plexin A4 (PLXNA4) Antibody

Ask
View Details
Plexin A4 (PLXNA4) Antibody
abx135910-03 200 µL

Plexin A4 (PLXNA4) Antibody

Ask
View Details
APC/CY7-Linked Polyclonal Antibody to Coiled Coil Domain Containing Protein 80 (CCDC80)
MBS2081901-01 0.1 mL

APC/CY7-Linked Polyclonal Antibody to Coiled Coil Domain Containing Protein 80 (CCDC80)

Ask
View Details
APC/CY7-Linked Polyclonal Antibody to Coiled Coil Domain Containing Protein 80 (CCDC80)
MBS2081901-02 0.2 mL

APC/CY7-Linked Polyclonal Antibody to Coiled Coil Domain Containing Protein 80 (CCDC80)

Ask
View Details